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During oncogenesis, cells acquire multiple genetic alterations that confer essential tumor-specific traits,
including immortalization, escape from antimitogenic signaling, neovascularization, invasiveness, andmeta-
static potential. In most instances, these alterations are thought to arise incrementally over years, if not
decades. However, recent progress in sequencing cancer genomes has begun to challenge this paradigm,
because a radically different phenomenon, termed chromothripsis, has been suggested to cause complex
intra- and interchromosomal rearrangements on short timescales. In this Review, we review established
pathways crucial for genome integrity and discuss how their dysfunction could precipitate widespread chro-
mosome breakage and rearrangement in the course of malignancy.Introduction
Decades of research have established that cancer is, at its
core, a genetic disease (Vogelstein and Kinzler, 2004). However,
unlike classical Mendelian disorders that are monogenically
transmitted via the germline, somatic alterations in multiple un-
linked loci (i.e., proto-oncogenes and tumor suppressor genes)
are generally required to produce most types of cancer,
whether sporadic or familial (Hanahan and Weinberg, 2011).
The coincidence of these events vastly exceeds their expected
frequency based on the locus-specific rates of single-nucleotide
changes (106 to 107 per division; Loeb et al., 2008) and
genomic rearrangements (104 to 105 per division; Lupski,
2007) in normal cells. Therefore, multistep carcinogenesis
requires genomic instability, due to either environmental geno-
toxic stressors (e.g., radiation or DNA-damaging compounds)
or diminished fidelity of endogenous DNA replication, repair,
and chromosome segregation pathways, in order to explain
the spectrum and extent of mutation in most tumors. Even with
this support, some premalignant lesions (e.g., adenomatous
polyps, Barrett’s esophagus, or cervical dysplasia) may still
take years to acquire the final mutation(s) needed for progression
into active disease (Fearon, 2011; Reid et al., 2010; Woodman
et al., 2007).
Nucleotide and Whole-Chromosome Instability
A small but important group of cancers is linked to elevated rates
of simple sequence changes (i.e., base substitutions, insertions,
or deletions affecting one or few contiguous nucleotides; Fig-
ure 1, left panel). For example, patients with xeroderma pigmen-
tosum lack a functional nucleotide excision repair (NER) path-
way and hence are unable to reverse DNA lesions induced
by UV light, resulting in widespread mutagenesis and cancer
development in sunlight-exposed regions of the epidermis (Leh-
mann et al., 2011). Similarly, inherited or somaticmutations in the
mismatch repair (MMR) machinery lead to error-prone replica-
tion and recombination of short DNA repeats known as microsa-
tellites, resulting in their dynamic expansion and contraction
across the genome, and account for 15% of colon cancers
(Umar et al., 2004). However, most solid tumors are associated
with a different form of genetic or genomic instability, whereby
whole chromosomes are gained or lost through mitotic misse-908 Developmental Cell 23, November 13, 2012 ª2012 Elsevier Inc.gregation (Schvartzman et al., 2010; Thompson et al., 2010)
(Figure 1, right panel). This tendency, often described as chro-
mosome instability (CIN), not only results in numerical deviation
from the normal 2N karyotype (i.e., aneuploidy) but also facili-
tates loss of heterozygosity, a key mechanism for tumor sup-
pressor gene inactivation (Baker et al., 2009). A number of mech-
anisms for CIN have been proposed, including dysregulation of
the spindle checkpoint, which restrains mitosis until all sister
chromatid pairs have been captured bymicrotubules from oppo-
site spindle poles (Musacchio and Salmon, 2007), centrosome
overduplication and multipolar spindle assembly (Bettencourt-
Dias et al., 2011), deficiencies in sister chromatid cohesion
(Solomon et al., 2011), and formation of improper kinetochore-
microtubule attachments that are not monitored by the spindle
checkpoint (i.e., merotelism; Bakhoum et al., 2009a, 2009b).
These pathways and their relevance to tumorigenesis have
been reviewed at length elsewhere (Holland and Cleveland,
2012; Schvartzman et al., 2010; Thompson et al., 2010).
Inter- and Intrachromosomal Rearrangements
In addition to whole-chromosome gains and losses, most cancer
genomes contain evidence of gross chromosomal rearrange-
ments (GCRs) (Figure 1, middle panel). This class of genomic
alterations has played a major role in the history of cancer
genetics, beginning with the discovery in 1960 of a recurrent
t(9;22) translocation (the ‘‘Philadelphia chromosome’’) in patients
with chronic myelogenous leukemia, resulting in expression of
the oncogenic BCR-ABL kinase fusion (reviewed in Mitelman
et al., 2007). Similarly, homozygous deletions affecting the long
arm of chromosome 13 (13q14) were crucial in identifying the
RB locus as the causative tumor suppressor in retinoblas-
toma (Berger et al., 2011), whereas high-copy amplifications of
17q21–17q22 were likewise important in delineating HER2/neu
as amajor oncogene and therapeutic target in breast and ovarian
cancer (Baselga and Swain, 2009).
Fundamentally, all GCRs stem from erroneous repair of
double-stranded DNA breaks (DSBs). Although often considered
in the context of exogenous sources of damage like ionizing
radiation (IR) or genotoxic drugs, the vast majority of DSBs
are caused by reactive oxygen species generated through
normal cellular metabolism, as well as by DNA replication and
Figure 1. The Spectrum of Genetic
Instability in Malignancy
Genomic alterations in tumors can be subdivided
into three main groups. At the smallest scale,
subtle sequence changes may affect one or
a few adjacent nucleotides (left). Examples in-
clude deficiencies in MMR and NER systems,
which result in unstable microsatellite repeats
(top) and retention of UV-induced photo-
products, such as thymine dimers (bottom). At
an intermediate scale (middle), GCRs, includ-
ing deletions, amplifications, inversions, and
translocations, are a ubiquitous feature of most
cancer genomes. GCRs can arise from multiple
mechanisms, including telomere erosion and end-
to-end fusion (depicted here), nonallelic HR,
replication stress, and chromothripsis. At the
largest scale, whole-chromosome instability
(right) causes not only aneuploidy but also loss of
heterozygosity (LOH), which is crucial for un-
masking recessive mutations in tumor suppressor
genes. This form of instability can result from
errors in virtually any aspect of mitosis, including dysregulation of the spindle assembly checkpoint, biogenesis of supernumerary centrosomes and multipolar
spindles, untimely dissolution of sister chromatid cohesion, and formation of merotelic kinetochore-microtubule attachments (arrows).
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2009). In specialized compartments (e.g., the adaptive immune
systems of jawed vertebrates and the germlines of most sexu-
ally reproducing species), programmed DSBs are intentionally
created to induce genetic diversity (Bassing and Alt, 2004; Sa-
saki et al., 2010). Because even a single unrepaired DSB would
lead to irreversible loss of genetic material, multiple repair sys-
tems of varying fidelity exist. However, this redundancy comes
at the price of collateral lesions caused by ‘‘off-target’’ DSB
repair.
Modes of DSB Repair
Broadly speaking, DSB repair mechanisms can be classified
according to their use of nonhomologous end-joining (NHEJ)
versus homologous recombination (HR) in the pairing and liga-
tion of exposed DNA ends (reviewed in Ciccia and Elledge,
2010). To a first approximation, this choice is dictated by cell-
cycle position, because HR requires a pre-existing sister chro-
matid and thus becomes available only during S and G2 phase
(Heyer et al., 2010). These pathways also differ in their repair
signatures. NHEJ ligates DSBs in an error-prone fashion, with
the repair junctions displaying little or no homology and fre-
quently marked by small deletions, insertions, or duplications
(Weinstock et al., 2006). In contrast, HR repairs DSBs in a poten-
tially error-free manner, via controlled single-stranded DNA
(ssDNA) resection to create free 30 ends that can recruit the
Rad51 recombinase and search for homology within the un-
broken sister chromatid (San Filippo et al., 2008). The presence
of dispersed high-copy repeats in complex genomes (e.g., Alu
elements) means that nonallelic HR is also possible, resulting
in mutagenic repair outcomes (e.g., deletions, inversions, and
reciprocal translocations; Moynahan and Jasin, 2010). Fortu-
nately, the frequency of such illegitimate recombination events
is considerably reduced by the divergent evolution of these
elements at the sequence level (Elliott and Jasin, 2001).
GCRs and Replication Stress
To a significant degree, our understanding of GCR-relevant
pathways has been shaped by genetic studies in Saccharo-Dmyces cerevisiae, a model system in which these rare events
can be positively selected and quantified over a wide dynamic
range, in both wild-type and mutant genetic backgrounds (Ko-
lodner et al., 2002). Importantly, the rearrangements detected
in these assays (interstitial or terminal deletions, reciprocal or
nonreciprocal translocations, and telomere addition) parallel
those observed in cancer genomes (Chen et al., 1998; Kolodner
et al., 2002; Myung et al., 2001). This approach exposed major
roles for multiple DNA replication- and recombination-linked
pathways, including the intra-S phase checkpoint (a surveillance
system that alleviates replication stress by stabilizing stalled
forks, inhibiting new origin firing, and delaying cell-cycle
progression) in GCR suppression (Myung et al., 2001). Although
the precise contribution of each branch remains to be eluci-
dated, mutations that compromise the intra-S phase checkpoint
in mammals are clearly linked to chromosome aberrations and
cancer predisposition (Bartek et al., 2004), suggesting that repli-
cation-dependent DSBs are a major source of GCRs during
malignancy. Consistently, it has been reported that overexpres-
sion of commonly activated oncogenes (e.g., H-RasV12) or S
phase regulators normally held in check by Rb and other pocket
proteins (e.g., Cdc6 and cyclin E) can induce both replication
stress and S phase-specific DSBs in primary cells (Bartkova
et al., 2006; Di Micco et al., 2006), possibly through precocious
origin firing and accelerated depletion of nucleotide pools (Bes-
ter et al., 2011).
Telomere Erosion and Chromosome Breakage-Fusion-
Bridge Cycles
GCRs can also arise through nonreplicative mechanisms, such
as the classic breakage-fusion-bridge (BFB) cycle first proposed
by McClintock (1941). Under this scenario, progressive telomere
shortening depletes the shelterin complex from chromosome
ends, resulting in their detection as (virtual) DSBs and ligation
via NHEJ (Palm and de Lange, 2008). Subsequent attempts to
segregate the fused and now-dicentric chromosome give rise
to anaphase bridges that can only be resolved through a new
round of chromosome breakage, thereby starting the cycle
anew (O’Sullivan and Karlseder, 2010). Iteration of this processevelopmental Cell 23, November 13, 2012 ª2012 Elsevier Inc. 909
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tion seen in telomerase-deficient mice (Artandi et al., 2000; Chin
et al., 1999). Interestingly, the frequency and complexity of these
alterations seem to be substantially greater than in telomerase-
proficientmouse cancermodels, similar to the situation in human
tumors (O’Hagan et al., 2002) and consistent with the notion that
telomere attrition is a significant early event in human (but not
murine) carcinogenesis.
Cancer Genomics and Chromothripsis
Historically, the extent of GCRs within tumors was inferred from
cytogenetic methods—such as spectral karyotyping (SKY) and
comparative genomic hybridization (CGH)—that survey chromo-
some integrity with megabase resolution. When applied to a
curated set of 60 cancer-derived cell lines, these techniques
identified 16 structurally aberrant chromosomes per tumor
(Roschke et al., 2003). However, recent advances in sequencing
and assembling cancer genomes suggested that these esti-
mates might be off by one or more orders of magnitude (Korbel
et al., 2007; Stephens et al., 2009). This discrepancy is most
clearly evident in the small fraction of solid tumors that
exhibit hundreds of GCR breakpoints that are clustered into
discrete subchromosomal territories (Stephens et al., 2011)
(see Figure 2 for illustrative examples). As discussed below,
statistical considerations have led to the proposal that this
unprecedented pattern of chromosome rearrangement (now
termed chromothripsis, after the Greek word for ‘‘shattering
into pieces’’) may occur as a single catastrophic event. Chromo-
thripsis has been invoked to explain similar clusters of GCRs
across a wide variety of tumor types (Kloosterman et al., 2011;
Lapuk et al., 2012; Magrangeas et al., 2011; Molenaar et al.,
2012; Rausch et al., 2012) (Table 1).
In general, genomic segments impacted by chromothripsis
tend todisplaypartial or complete lossof genetic information (i.e.,
hemizygous or homozygous deletion), rather than a balanced
mix of gains and losses. Based on in silico modeling, it has
been argued that this pattern is a poor fit with models in which
GCRs are induced sequentially over time, rather than in a single
massively parallel event (Stephens et al., 2011). On the other
hand, because the underlying rates and mechanisms of GCR
induction are unknown, serial models in which losses and gains
are generated in unequal proportions (or alternatively associated
with differences in cellular fitness during clonal expansion)
cannot be excluded at this point.
What induces the massive, localized, and perhaps synchro-
nous wave of DSBs during chromothripsis? Various triggers
have been suggested, including IR, telomere erosion and BFB
cycles, abortive apoptosis, premature chromosome compac-
tion, and replication stress (Figure 3). Here we discuss these
mechanisms and how they may account for the signature
patterns of chromosome rearrangements in chromothripsis-
positive tumors.
IR and Telomere Erosion
The initial observation that tens to hundreds of DSBs were
clustered into relatively small (megabase-sized) chromosomal
regions led Campbell and colleagues (Stephens et al., 2011) to
propose a model in which a stray pulse of IR travels through
a small subcompartment of the interphase nucleus (Misteli,910 Developmental Cell 23, November 13, 2012 ª2012 Elsevier Inc.2007) or, perhaps more plausibly, a condensed mitotic chromo-
some, thereby generating a spatially restricted zone of DNA
damage. Although difficult to exclude, this model is somewhat
constrained by the fact that few natural sources of IR are both
strong enough and sufficiently focused to deliver 2–4 Gy (the
energy required to create 50–100 DSBs) into a subpicoliter target
volume while simultaneously avoiding the rest of the genome. (In
comparison, the average person receives a cumulative dose of
2.5 mGy/year from environmental sources of IR.) Further
refinement of this model (for example, under conditions of ther-
apeutic or accidental exposure to high-dose IR) is therefore
warranted.
A second suggestion relates to the BFB cycles previously dis-
cussed that are precipitated by telomere erosion. Specifically,
excess stretching of the bridging chromosome by the anaphase
spindle and/or physical entrapment by the cytokinetic furrow
might not result in a single DSB but rather in a series of closely
spaced breaks (Stephens et al., 2011). On the one hand, this
idea is consistent with the fact that laggingmitotic chromosomes
trapped within the furrow can indeed undergo breakage and re-
joining, resulting in nonreciprocal translocations (Janssen et al.,
2011), and also supported by examples of complex rearrange-
ments involving telomeric or subtelomeric regions (Stephens
et al., 2011). However, most chromothripsis-associated rear-
rangements neither affect chromosome ends nor implicate a
dicentric fusion as an intermediate and thus are difficult to
explain through this particular mechanism.
Abortive Apoptosis
Endonucleolytic DNA cleavage is a key aspect of programmed
cell death (Taylor et al., 2008). Consequently, it has been pro-
posed that chromothripsis arises from rare instances where
apoptosis was transiently initiated and then aborted (Tubio and
Estivill, 2011). Although an intriguing hypothesis, how cells might
escape not only complete DNA fragmentation but also endonu-
clease-independent cell death pathways remains to be clarified.
One possibility is that cleavage is restricted to regions of high
chromatin accessibility or influenced by the activity of viruses
that inhibit apoptosis (Tubio and Estivill, 2011). Importantly,
this hypothesis makes the striking and testable prediction that
mice lacking key apoptotic nucleases (e.g., caspase-activated
DNase and endonuclease G; Samejima and Earnshaw, 2005)
will be prevented from inducing chromothripsis-dependent
tumors in vivo.
Replication Stress and Mitotic Errors: A Synergistic
Combination?
In our view, replication stress must be considered a prime
suspect among potential inducers of chromothripsis (Figure 3).
As noted above, commonly activated oncogenes and targets
of the Rb-E2F circuit are known to induce premature fork
termination, S phase checkpoint signaling, and DSBs in other-
wise naive human cells, at least in part due to the accelerated
consumption of nucleotide precursors. Likewise, the resulting
tendency of replication forks to stall or collapse at so-called
‘‘fragile sites,’’ which are especially hard to duplicate fully
because of their low origin density (Letessier et al., 2011), may
explain the apparent clustering of DSBs within a subchromoso-
mal region (Figure 3B).
Figure 2. Manifestations of Chromothripsis in Human Tumors
(A) Sequencing of a chordoma (notochord-derived tumor) reveals 147 linkages among chromosomes (Chr) 3q, 4q, 7q, 8p, and 9p, as well as various intra-
chromosomal rearrangements. Copy number profiles and allelic ratios are displayed in outer and inner rings of the circos plot. Adapted from Stephens et al.
(2011).
(B) SKY of pancreatic adenocarcinoma. Enlargement shows a derivative chromosome containing at least six distinct regions from heterologous chromosomes,
including 22, 1, 4, 10, and 14. Note that formation of this derivative has resulted in multiple monosomies, indicating widespread allelic and copy number losses.
Adapted from Stephens et al. (2011).
(C) Chromothripsis in a Sonic hedgehog (Shh)-type medulloblastoma arising in a patient with LFS. The circos plot on the left shows a double minute generated
through fragmentation of chromosome 2. Twomajormediators of Shh signaling,MYCN andGLI2, are contained in this 5Mb interval. On the right is a fluorescence
in situ hybridization (FISH) experiment confirming ubiquitous amplification of bothMYCN (red) andGLI2 (green) in the primary tumor. Adapted from Rausch et al.
(2012).
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Table 1. Chromothripsis in Human Malignancies
Tumor Type Chromothripsis Incidence Recurrently Affected Loci (Examples) Reference
Cancer-derived cell lines (multiple sites) 2.4% (n = 746) MYC, CDKN2A, AVEN, IDH2, PML,
RYR3, TCF12, MLLT3
Stephens et al. (2011)
Chronic lymphocytic leukemia 10% (n = 10) CDKN2A, miR-15a/16-1 Stephens et al. (2011)
Osteosarcoma 33% (n = 9) Stephens et al. (2011)
Chordoma 18% (n = 11) CDKN2A, FBXW7, WRN, ARID1A Stephens et al. (2011)
Neuroblastoma 11% (n = 87) MYCN, CDK4, C-MYC, FAN1, FANCM,
ATRX, ODZ3, PTPRD, CSMD1, TIAM1
Molenaar et al. (2012)
Medulloblastoma (all types) 13% (n = 98) MYCN, GLI2 Rausch et al. (2012)
Sonic Hedgehog subtype medulloblastoma
(SHH-MB) with point-mutated TP53
100% (n = 10) BOC, ADAM2A, NEK11, CDK6,
NAMPT, IGF1R, MYCN, GLI2
Rausch et al. (2012)
SHH-MB with hemizygous TP53 loss 33% (n = 3) Rausch et al. (2012)
SHH-MB with wild-type TP53 0% (n = 22) Rausch et al. (2012)
WNT-MB 0% (n = 11) Rausch et al. (2012)
Multiple myeloma 1.3% (n = 764) Magrangeas et al. (2011)
Colorectal carcinoma not indicated NOTCH2, EXO1, MLL3 Kloosterman et al. (2011)
Information on the incidence, organ/tissue distribution, and target loci affected by chromothripsis was extracted from the indicated studies and
summarized herein.
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during S phase, replication stress can induce genomic instability
on a delayed basis. This possibility arises because certain types
of replication intermediates (specifically those that do not
expose long tracts of ssDNA) activate the DNA damage
response inefficiently if at all, thus allowing cells to enterM phase
in their presence (Chan et al., 2009; Lukas et al., 2011). Ensuing
attempts to compact these unresolved intermediates into
mitotic chromosomes can then induce DNA damage de novo
(Lukas et al., 2011) and, thus, may be a source of DSBs during
chromothripsis (Maher and Wilson, 2012) (Figure 3B). Such
haphazard chromatin compaction is reminiscent of the now-
classic findings of Rao and Johnson, who found that fusing
S phase and mitotic cells caused the nuclei of the former to
enter mitosis prematurely, resulting in unscheduled chromatin
condensation and fragmentation (Rao and Johnson, 1970).
Moreover, recent work indicates that mitotic errors can play
a primary role in fomenting replication stress. In particular, intact
chromosomes that missegregated during anaphase were
found to form extranuclear bodies (micronuclei) that import key
replication factors inefficiently, resulting in sluggish and DSB-
prone DNA synthesis, as well as aberrant chromatin compaction
and fragmentation in the next mitosis (Crasta et al., 2012)
(Figure 3C). Whether whole-chromosome aneuploidy stimulates
chromothripsis in vivo remains to be addressed but in principle
ought to be evident in mouse models of CIN that generate
aneuploidy at high rates (Schvartzman et al., 2010). Collectively,
these results suggest ways in which replication stress and
mitotic errors can synergize over one or a few cell divisions
to establish the high degree of genomic instability needed for
chromothripsis.
Chromothripsis and p53
Interestingly, complex chromosome rearrangements resembling
chromothripsis have also been found in the tumors of patients
affected by Li-Fraumeni syndrome (LFS), a cancer predisposi-912 Developmental Cell 23, November 13, 2012 ª2012 Elsevier Inc.tion syndrome caused by germline mutations in the TP53 (p53)
tumor suppressor (Li and Fraumeni, 1969; Rausch et al., 2012).
The effect of p53 inactivation seems to be especially pro-
nounced in medulloblastomas (tumors of the cerebellum and
brain stem) driven by excess Sonic Hedgehog activity: essen-
tially all such tumors undergo chromothripsis if they arise in
patients with LFS but rarely if ever do so in patients with wild-
type TP53 alleles (Table 1). In principle, p53 inactivation might
support chromothripsis by preventing cells with high levels of
DSBs from being eliminated via p53-mediated cell-cycle arrest,
apoptosis, or senescence (Bartek et al., 2004). Alternatively, loss
of p53-dependent control over S phase entry may conspire with
latent sources of replication stress (e.g., activated oncogenes or
postmitotic micronuclei) to trigger DSBs directly (Bester et al.,
2011; Crasta et al., 2012) (Figure 3C).
Possible Mechanisms of Chromosome Reassembly and
Resynthesis
Ultimately, the breaks created in the first stage of chromothripsis
must be healed by one of several DNA repair systems, each
of which has a characteristic signature. In the case of cancer-
associated chromothripsis, most breakpoint junctions exhibit
tracts of microhomology, as well as variably sized deletions
and insertions of nucleotides (Rausch et al., 2012; Stephens
et al., 2011). Together, these features suggest the predominant
use of nonreplicative repair pathways (Figure 4A), specifically
NHEJ and microhomology-mediated end-joining (MMEJ). The
former uses the Ku70-Ku80 heterodimer and DNA-dependent
protein kinase (DNA-PK) to recognize, process, and ligate DSB
ends via short (0–5 bp) stretches of microhomology, often with
the insertion or removal of a few nucleotides (Figure 5A). In con-
trast, MMEJ uses Ku- and DNA-PK-independent strand re-
section to expose somewhat longer (5–25 bp) microhomology
tracts. Subsequent annealing and flap trimming produce the final
mutagenic repair products, which are skewed toward deletions
and translocations (Lieber, 2010) (Figure 5A).
Figure 3. Replication Stress and Mitotic Errors May Synergize to Induce High Levels of Genomic Instability and Precipitate Chromothripsis
(A) Untransformed cells pass through mitosis normally, resulting in correct partitioning of sister genomes in daughter cell nuclei. Once the restriction point is
passed, orderly activation of replication origins leads to faithful S phase progression and genome duplication with minimal loads of incidental DSBs.
(B) Under the influence of activated oncogenes, G1/S phase regulation is corrupted, leading to inappropriate firing of replication origins, depletion of nucleotide
precursors, and elevated rates of fork stalling and collapse. Such replication stress may be particularly severe in hard-to-duplicate regions of the genome that
harbor low densities of replication origins (i.e., ‘‘fragile sites’’) and thus demand high fork processivity.
(C) Replication stress can be induced by antecedent mitotic errors. Whole-chromosome segregation errors frequently result in the formation of postmitotic
micronuclei and also trigger a p53-dependent arrest in late G1 phase (Uetake and Sluder, 2010). However, if p53 is mutated or experimentally inactivated,
micronucleated cells can proceed into S phase, resulting in delayed and breakage-prone DNA synthesis within the micronucleus. In addition, persistent repli-
cation intermediates within themicronucleus can be further destabilized by transit into mitosis, resulting in haphazard chromatin compaction and ‘‘pulverization.’’
A similar fate can also befall lagging anaphase chromatids generated through other mechanisms (for example, telomere erosion and end-to-end fusion, resulting
in a dicentric chromosome).
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genetic information during chromothripsis, they cannot easily
explain how other genomic regions become amplified at the
same time (Magrangeas et al., 2011; Rausch et al., 2012;
Stephens et al., 2011). Instead, recent analyses of germline
chromothripsis in patients with congenital neurodevelopmental
disorders (Kloosterman et al., 2012; Liu et al., 2011) suggest
that replication-based repair pathways can support both copyDnumber gains and losses (Chen et al., 2012; Hastings et al.,
2009; Liu et al., 2012) (Figure 4B). Indeed, such pathways have
recently been implicated in the amplification of subtelomeric
regions (Yatsenko et al., 2012). These pathways, variously re-
ferred to as microhomology-mediated break-induced replica-
tion (MMBIR) or replication fork stalling and template switching
(FoSTeS), begin by converting the one-sided DSB associated
with a collapsed fork into a free 30 end (Figure 5B). Throughevelopmental Cell 23, November 13, 2012 ª2012 Elsevier Inc. 913
Figure 4. Error-Prone Modes of DNA Repair
May Underlie Chromothripsis
(A) Nonreplicative end joining. Intense but local-
ized induction of DSBs may liberate genomic
fragments that are recognized, processed, and
ligated by one of several end-joining pathways
that are intrinsically error prone (see figure for
mechanistic details). Fragments not ligated to the
founding chromosome ‘‘stub’’ either self-ligate to
form extrachromosomal arrays (double minutes)
or are lost from the genome entirely.
(B) Mutagenic fork restart. Under conditions where
HR-dependent pathways are compromised or
limiting, a collapsed replication fork may be re-
started via microhomology-mediated template
switching. This error-prone mode of lesion bypass
can generate the full spectrum of structural alter-
ations, including deletions, amplifications, inver-
sions, and nonreciprocal translocations (see figure
for mechanistic details).
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and exposed ssDNA regions at nearby replication forks, the
resumption of DNA synthesis becomes possible. However,
because such forks are only weakly processive, most rounds
of DNA synthesis are punctuated by fork disassembly and
release of the extension products, thereby licensing further
cycles of template switching. Depending on whether the switch
involves sequences on the same chromosome, its homolog, or
a different chromosome, complex deletions, amplifications,
and nonreciprocal translocations can be generated (Figure 5B).
In addition, more elaborate template switches involving pairs
of replication forks (i.e., replication bubbles) have been proposed
to explain certain complex rearrangements in human breast
cancer cell lines (Howarth et al., 2011) and may also contribute
to chromothripsis.
What drives cells to use these DNA repair pathways, given
their low fidelity? One possibility is that other mutations within
the tumor reduce the prospects for error-free repair, even under
conditions where a sister chromatid is present. In the case of
familial breast and ovarian tumors, attenuated HR-dependent
repair can be explained by germline alterations in BRCA1 and
BRCA2, which regulate DSB metabolism at multiple levels (Roy
et al., 2012). Alternatively, high loads of replication-dependent
DSBs may overwhelm the HR machinery even if it is present at914 Developmental Cell 23, November 13, 2012 ª2012 Elsevier Inc.full strength. For example, recent work
suggests that as few as 20 DSBs can
saturate one key aspect of the DNA
damage response (chromatin ubiquityla-
tion) that is important for shaping repair
outcomes (Gudjonsson et al., 2012).
Thus, DSBs in excess of this threshold
may lack an error-free option for repair.
Because the breakpoints generated by
MMBIR and MMEJ/NHEJ are somewhat
overlapping due to their use of microho-
mology, further work will be required to
clarify whether the two pathways are
indeed mutually exclusive during germ-
line versus somatic chromothripsis or,
instead, are active to differing degreesin both tissue contexts. In part, this will require functional studies
that look at the dynamics of (and requirements for) DSB induc-
tion and resolution in chromothripsis-prone animal and cell
culture models.
Concluding Perspective: The Costs and Benefits
of Chromothripsis
Similar to aneuploidy (Siegel and Amon, 2012), chromothripsis
deranges the structure and dosage of multiple genes at one
stroke, through the induction of extensive rearrangements
involving one or several subchromosomal regions (Figure 2).
Although such random changes may occasionally enhance
growth by disrupting haploinsufficient tumor suppressor
genes (Berger and Pandolfi, 2011; Solimini et al., 2012; Xue
et al., 2012) or activating proto-oncogenes, most would be
expected to result in deleterious consequences (e.g., derange-
ment of essential or dosage-sensitive genes) and thus be
prone to elimination during clonal outgrowth. Moreover, the
DSBs required to produce both beneficial and detrimental
rearrangements are themselves liable to inhibit proliferation via
activation of the DNA damage response (Jackson and Bartek,
2009). Collectively, these adverse selection pressures may ex-
plain why chromothripsis is relatively rare (or at least rarely
results in clonal fixation) in most forms of cancer. On the other
Figure 5. Mechanisms and Signatures of Mutagenic Chromosome Reassembly
(A) Nonreplicative end-joining pathways. Under NHEJ, DSB ends are first recognized and protected from resection by the Ku70-Ku80 heterodimer. Subsequent
interactions between DSB ends occur via short (0–5 bp) patches of microhomology. One to four nucleotides are then added or removed to create a ligatable end,
resulting in an imprecise junction or ‘‘information scar’’ at the breakpoint. In contrast, MMEJ uses Ku-independent strand resection to expose longer (5–25 bp)
microhomology tracts. After annealing of these tracts, the resulting 30 flaps are trimmed off prior to fill-in synthesis and ligation. Consequently, the final repair
products generated by MMEJ typically contain variably sized deletions as well as nucleotide insertions.
(B) MMBIR is initiated when a replication fork collapses, resulting in a single-ended DSB (black lines; for clarity, the nicked or gapped duplex representing the
opposite side of the collapsed fork has been omitted). Thereafter, the 50 end of the broken arm is resected to reveal a free 30 ssDNA tail, which then uses short-
tract microhomology (2–5 nucleotides) to anneal with other exposed ssDNAs, such as the lagging strand of an upstream replication fork (red lines). Elongation
of this primer-template junction occurs with low processivity, resulting in eventual fork disassembly, release of the extension products, and further cycles of
template switching. Although a switch back to the original sister chromatid can reestablish processive DNA replication (resulting in a segmental duplication or
higher-order amplification), interchromosomal switching can also occur, resulting in a complex nonreciprocal translocation.
Developmental Cell
Reviewhand, under circumstances where a sufficiently large population
of cells can initiate and survive chromosome breakage, the
probability of recovering clones with one or more beneficial
‘‘driver’’ alterations and a minimal load of deleterious
‘‘passenger’’ mutations might be close to 100%. Clearly, further
experimental work and evolutionary modeling are needed to
illuminate both the costs and benefits of chromothripsis,
especially as compared with more incremental and chronic
forms of genetic instability (Figure 1). Although potentially
offering a shortcut to the acquisition of multiple cancer-causing
mutations, chromothripsis may also make tumors vulnerable to
therapeutic strategies that specifically target regions of genomic
loss (Nijhawan et al., 2012) and hence sharply escalate the
negative costs associated with ‘‘passenger’’ rearrangements.
One attractive venue for exploring this therapeutic concept is
afforded by Sonic hedgehog-dependent medulloblastoma,
which undergoes chromothripsis uniformly in the absence of
p53 (Rausch et al., 2012). If such personalized genomics-based
treatments can indeed be realized, then the recent discovery of
chromothripsis in human tumors might someday be considered
a lucky break.ACKNOWLEDGMENTS
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